Home › Funds › Kepos Capital LP › DMII
Kepos Capital LP position in DMII
DRUGS MADE IN AMER ACQ II CO · Financials
Kepos Capital LP reported holding 210,000 shares of DMII (DRUGS MADE IN AMER ACQ II CO) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 3.05% of its reported portfolio and ranking #4 among its reported holdings. Kepos Capital LP has disclosed DMII holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Kepos Capital LP's DMII position evolved
Kepos Capital LP first disclosed a stake in DMII in Q2 2026 at 210,000 shares (US$2.1M). The position peaked in Q3 2026 at 210,000 shares, worth US$2.1M. Across 2 filings, Kepos Capital LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 210,000 shares valued at US$2.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 210.00K | $2.11M | New |
| Q3 2026 | 210.00K | $2.14M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DMII and 13F data
DMII (DRUGS MADE IN AMER ACQ II CO) is a Financials company. 71 other funds we track also report a position in DMII — the largest reported positions include Karpus Management, Inc. (US$28.0M), Magnetar Financial LLC (US$27.5M), MMCAP International Inc. SPC (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DMII
- Karpus Management, Inc. 2.79M sh · $28.05M · Q2 2026
- Magnetar Financial LLC 2.70M sh · $27.51M · Q3 2026
- MMCAP International Inc. SPC 2.70M sh · $27.49M · Q3 2026
- GLAZER CAPITAL, LLC 2.34M sh · $23.57M · Q2 2026
- HIGHBRIDGE CAPITAL MANAGEMENT LLC 2.24M sh · $22.57M · Q2 2026
- WOLVERINE ASSET MANAGEMENT LLC 1.84M sh · $18.75M · Q3 2026
- First Trust Capital Management L.P. 1.30M sh · $13.22M · Q3 2026
- Crossingbridge Advisors, LLC 1.10M sh · $11.20M · Q3 2026
- Mercuria Capital Strategies, LLC 750.00K sh · $7.63M · Q3 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 519.40K sh · $5.23M · Q2 2026
- TIG Advisors, LLC 500.00K sh · $5.03M · Q2 2026
- Wealthspring Capital LLC 399.15K sh · $4.06M · Q3 2026
More on Kepos Capital LP
FAQ
How long has Kepos Capital LP held DMII?
Kepos Capital LP has disclosed DMII holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Kepos Capital LP's current position in DMII?
As of Q3 2026, Kepos Capital LP holds 210.00K shares of DMII (DRUGS MADE IN AMER ACQ II CO), valued at $2.14M, representing 3.05% of its reported portfolio and ranking #4.
Has Kepos Capital LP been buying or selling DMII?
In the latest 13F filing (Q3 2026), Kepos Capital LP held unchanged its position in DMII. The position peaked in Q3 2026 at 210.00K shares.
Which other funds hold DMII?
Other major institutional holders of DMII include Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.